Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

20181,237 citationsJournal Articlehybrid Open Access

Authors

Christopher Parker · Royal Marsden Hospital

Nicholas D. James · University of Birmingham

Chris Brawley · Medical Research Council

Noel W. Clarke · Salford Royal Hospital

Alex Hoyle · The Christie Hospital

Adnan Ali · Cancer Research UK

A.W.S. Ritchie ·

Abstract

Cancer Research UK, UK Medical Research Council, Swiss Group for Clinical Cancer Research, Astellas, Clovis Oncology, Janssen, Novartis, Pfizer, and Sanofi-Aventis.

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Hepatocellular Carcinoma Treatment and Prognosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Lancet

Volume 392, Issue 10162, pp. 2353-2366

DOI: 10.1016/s0140-6736(18)32486-3

Field-Weighted Citation Impact: 105.80